Literature DB >> 30151713

Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.

Julaluck Promsorn1, Wannaporn Soontrapa2, Kulyada Somsap2, Nittaya Chamadol2, Panita Limpawattana3, Mukesh Harisinghani4.   

Abstract

INTRODUCTION: Cholangiocarcinoma (CCA) is the primary tumor found in the bile duct and is associated with a high incidence of lymph node (LN) metastases and poor outcomes. The presence of metastatic lymph nodes, when shown by imaging, can influence patient treatment and prognosis. DWI is a promising, non-invasive imaging technique for differentiating between benign and malignant LNs. Many studies have shown that LN metastases have a lower apparent diffusion coefficient (ADC) value when compared to benign nodes.
OBJECTIVE: To evaluate the performance of ADC values as a basis for diagnosis of LN metastasis in cholangiocarcinoma patients.
MATERIALS AND METHODS: This was a retrospective imaging study that evaluated histopathologically proven intraabdominal LNs in cholangiocarcinoma patients who underwent a 1.5T abdomen MRI with DWI between January 2012 and July 2016. The ADC values and short-axis diameters of the LNs were measured and compared using student's t test. Receiver operating characteristic (ROC) curves were used to determine the threshold.
RESULTS: A total of 120 lymph nodes-85 benign and 35 metastatic-were included. The mean short-axis diameter of the benign LNs (8.34 mm) was significantly lesser than that of the malignant LNs (9.56 mm). Receiver operating characteristic curve analysis using a size criterion of 1 cm yielded a value of 0.63. A diagnostic size criterion of 1 cm for the short axis was applied and yielded an accuracy of 66%, sensitivity/specificity of 41%/75%, and positive/negative predictive value of 34%/80%. The mean ADC values of metastatic (1.31 × 10-3 mm2/s) LNs were not significantly different from those of non-metastatic LNs (1.29 × 10-3 mm2/s).
CONCLUSION: There was no difference in terms of ADC value between benign lymph nodes and those with metastatic cholangiocarcinoma. Isolated measurement of the ADC value does not contribute to a diagnosis of lymph node metastasis.

Entities:  

Keywords:  ADC measurement; Cholangiocarcinoma lymph node metastasis; DWI

Mesh:

Year:  2019        PMID: 30151713     DOI: 10.1007/s00261-018-1742-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

1.  Incidental biliary dilation in the era of the opiate epidemic: High prevalence of biliary dilation in opiate users evaluated in the Emergency Department.

Authors:  Monique T Barakat; Subhas Banerjee
Journal:  World J Hepatol       Date:  2020-12-27

2.  Clinical Staging of Mass-Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging.

Authors:  Yeun-Yoon Kim; Suk-Keu Yeom; Seung Soo Lee; Mi-Suk Park; Hyejung Shin; Sang Hyun Choi; Hyungjin Rhee; Ji Hoon Park; Eun-Suk Cho; Sumi Park
Journal:  Hepatol Commun       Date:  2021-08-24

3.  Establishment of a multi-parameters MRI model for predicting small lymph nodes metastases (<10 mm) in patients with resected pancreatic ductal adenocarcinoma.

Authors:  Yan-Jie Shi; Bo-Nan Liu; Xiao-Ting Li; Hai-Tao Zhu; Yi-Yuan Wei; Bo Zhao; Shao-Shuai Sun; Ying-Shi Sun; Chun-Yi Hao
Journal:  Abdom Radiol (NY)       Date:  2021-11-20

4.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in assessing lymph node metastasis of esophageal cancer compared with PET.

Authors:  Kiyohiko Shuto; Tsuguaki Kono; Toru Shiratori; Yasunori Akutsu; Masaya Uesato; Mikito Mori; Kazuo Narushima; Shunsuke Imanishi; Yoshihiro Nabeya; Noriyuki Yanagawa; Shinichi Okazumi; Keiji Koda; Hisahiro Matsubara
Journal:  Esophagus       Date:  2019-12-09       Impact factor: 4.230

5.  Associations Between Apparent Diffusion Coefficient Value With Pathological Type, Histologic Grade, and Presence of Lymph Node Metastases of Esophageal Carcinoma.

Authors:  Yating Wang; Genji Bai; Lili Guo; Wei Chen
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

Review 6.  Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach.

Authors:  Felix Krenzien; Nora Nevermann; Alina Krombholz; Christian Benzing; Philipp Haber; Uli Fehrenbach; Georg Lurje; Uwe Pelzer; Johann Pratschke; Moritz Schmelzle; Wenzel Schöning
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.